Alzheimer’s disease is a progressive memory disorder that affects nearly one in three seniors and is on the rise, currently affecting 43 million people worldwide.
Behind the memory impairments, there is a perfect storm of destruction in the brain, stemming in part from accumulations of a protein called tau. Normally a stabilizing structure inside of neurons, tau can accumulate in long tangles that disrupt the ability of neurons to communicate with one another.
University of New Mexico researchers have developed a vaccine that could prevent the formation of the tau tangles and potentially prevent the cognitive decline typically seen in Alzheimer’s patients.
In a paper published last week in NPJ Vaccines, the team reported it had engineered a vaccine using virus-like particles (VLPs, for short) that eliminated the tau tangles in mice that had been bred to develop symptoms like those affecting human Alzheimer’s patients.
“We’re excited by these findings, because they seem to suggest that we can use the body’s own immune system to make antibodies against these tangles, and that these antibodies actually bind and clear these tau tangles,” said Nicole Maphis, a PhD candidate in UNM’s Biomedical Sciences Graduate Program.
Maphis, working in the lab of Kiran Bhaskar, PhD, an associate professor in UNM’s Department of Molecular Genetics & Microbiology, found that when the vaccine was given to mice, they developed antibodies that cleared the tau protein from their brains – and the response lasted for months.
Then, she tested the animals in a battery of maze-like tests. Mice receiving the vaccination performed remarkably better than those that hadn’t. MRI scans showed that the vaccinated animals had less brain shrinkage, suggesting that the vaccine prevented neurons from dying.
Maphis also found significantly fewer tangles in both the cortex and the hippocampus – areas in the brain that are important for learning and memory, and which are destroyed in Alzheimer’s.
“These results confirm that targeting tau tangles using a vaccine intervention could rescue memory impairments and prevent neurons from dying,” Maphis said.
The vaccine was created with help from UNM scientists David Peabody and Bryce Chackerian. The pair helped pioneer the use of VLPs to create vaccines targeting dengue virus, hepatitis B, human papillomavirus and amyloid beta protein (which is also present in the brains of Alzheimer’s patients).
VLPs are derived from viruses that have their genomes removed, leaving only their outer protein shell. Lacking a genome, they’re unable to reproduce, but the body’s immune system still recognizes them as foreign invaders and manufactures antibodies to neutralize the proteins attached to their surface. In this case, a portion of tau protein on the surface of the VLP triggers an immune response, leading to the elimination of the tau tangles.
Going forward, Bhaskar hopes to obtain funding to commercialize this vaccine in order to create an injection that could potentially be tested in human patients. However, moving a drug from bench to bedside can cost millions of dollars and take decades.
By partnering with AgilVax, Inc., a company formed to commercialize the VLP technology, and STC.UNM (UNM’s technology commercialization arm), Bhaskar hopes to receive funding from a federal Small Business Innovation Research grant to help move the research project forward.
Learn more: Memory Preserver
The Latest on: Alzheimer’s vaccine
via Google News
The Latest on: Alzheimer’s vaccine
- The latest updates on the global search for a coronavirus vaccineon October 7, 2020 at 12:04 pm
Whether you're worried about the economy or when you'll next be able to see your family in person, you're probably wondering when a coronavirus vaccine will be ready. These are the latest developments ...
- The race for covid-19 vaccine: Why this month is criticalon October 1, 2020 at 9:32 pm
Pfizer Inc. and German partner BioNTech SE this month plan to reveal late-stage results showing whether or not their two-shot regimen is effective in preventing the spread of the virus.Novavax Inc. is ...
- Getting These Vaccines Could Lower Your Alzheimer’s Riskon October 1, 2020 at 5:00 pm
Getting a flu shot is always wise, but especially so this year. It's not the usual blah, blah, blah. Click here to sign up for our free newsletter. The vaccine helps protect against influenza, which ...
- Coronavirus Vaccine Study Out Of UCHealth Shows How Antibodies React With Older Adultson September 30, 2020 at 4:33 pm
Early results of a coronavirus vaccine study being conducted in Colorado show that the vaccine candidate in older adults produced virus-neutralizing antibodies at levels similar to those seen in ...
- The surprising future of vaccine technologyon September 30, 2020 at 3:18 am
We owe a lot to vaccines and the scientists that develop them. But we've only just touched the surface of what vaccines can do.
- Study shows link between sleep apnea and Alzheimer’son September 29, 2020 at 9:47 am
The patients in the study showed no clinical symptoms of dementia before they died ... encouraging families to get their child's flu shot before October 31 to make the vaccine most effective. The key ...
- Pfizer CEO on the pressures of creating a covid-19 vaccine: ‘What is at stake is beyond imagination’on September 29, 2020 at 8:30 am
Bourla is a doctor of veterinary medicine and began his career at Pfizer 27 years ago in his home country of Greece. Support our journalism. Subscribe today. The global pandemic hit just a year into ...
- Will a vaccine really be the silver bullet we're all praying for? Asks DR ELLIE CANNONon September 26, 2020 at 3:01 pm
Ask any scientist who knows what they're talking about and they'll tell you the vaccine just isn't going to provide this kind of resolution.
- Everybody wants a vaccine, but who's going to foot the bill?on September 25, 2020 at 6:07 am
Rich countries have moved aggressively to lock down sufficient vaccine doses for their citizens, but few have invested in ensuring there’s an effective vaccine, in the first place. And even big ...
- The fastest Covid-19 vaccine might not be best & familiar bad news in Alzheimer’son September 24, 2020 at 5:14 pm
Welcome to The Readout, your guide to what's new in biotech.
via Bing News